Keywords: fda, advisory, meeting, discuss, safety, biologics, ra

FDA advisory meeting to discuss safety of biologics for RA at March meeting

Article | 03 February 2003

Print This

The safety of biologic therapies for rheumatoid arthritis which targettumor necrosis factor is to be debated at a US Food ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in